Starting in the late 1980s[36] the FDA increased its involvement in reviewing the development of medical device software. The precipitant for change was a radiation therapy device (Therac-25) that overdosed patients because of software coding errors.[37] FDA is now focused on regulatory oversight on medical device software development process and system-level testing.[38]